pyrroles has been researched along with Palsy in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Y; Shao, X; Xie, K; Yin, H; Zeng, T; Zhang, C; Zhao, X | 1 |
Bravo, M; Hur, EM; Mitchell, DJ; Patarroyo, JC; Radosevich, JL; Ruiz, PJ; Sobel, RA; Steinman, L; Stüve, O; Youssef, S; Zamvil, SS | 1 |
Aktas, O; Brocke, S; Dorr, J; Endres, M; Nitsch, R; Prozorovski, T; Sallach, S; Seeger, B; Smorodchenko, A; Waiczies, S; Zipp, F | 1 |
THIELE, S; WITH, TK | 1 |
Barbosa, E; Christie, DK; Pannu, R; Singh, AK; Singh, I | 1 |
Erwin, WD; Gullikson, GW; Loeffler, R; Virina, MA | 1 |
Grafe, P; Lehmann-Horn, F; Spuler, A | 1 |
7 other study(ies) available for pyrroles and Palsy
Article | Year |
---|---|
Biological exposure indices of pyrrole adducts in serum and urine for hazard assessment of n-hexane exposure.
Topics: Adult; Animals; Biomarkers; Body Weight; Female; Gait; Hexanes; Humans; Male; Middle Aged; Occupational Exposure; Paralysis; Presynaptic Terminals; Pyrroles; Rats; Time Factors; Young Adult | 2014 |
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Antigen-Presenting Cells; Atorvastatin; Cell Division; Central Nervous System Diseases; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Microglia; Molecular Sequence Data; Multiple Sclerosis; Nuclear Proteins; Paralysis; Phosphorylation; Pyrroles; RNA, Messenger; STAT4 Transcription Factor; STAT6 Transcription Factor; Th2 Cells; Trans-Activators | 2002 |
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
Topics: Animals; Apoptosis; Atorvastatin; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Female; Genes, MHC Class II; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Paralysis; Peptide Fragments; Pyrroles; Recurrence; Spinal Cord; Th1 Cells | 2003 |
ACUTE INTERMITTENT PORPHYRIA; DIAGNOSIS FOUR YEARS POST MORTEM BY CHEMICAL STUDIES IN RELATIVES.
Topics: Diagnosis, Differential; Genetics, Medical; Humans; Levulinic Acids; Necrosis; Pancreas; Paralysis; Porphyria, Acute Intermittent; Porphyrias; Porphyrins; Pyrroles; Urine | 1964 |
Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
Topics: Animals; Atorvastatin; Blood-Brain Barrier; Chemotaxis, Leukocyte; Cytokines; Down-Regulation; Endothelial Cells; Female; Gait Disorders, Neurologic; Heptanoic Acids; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroprotective Agents; Paralysis; Pyrroles; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; rhoA GTP-Binding Protein; Spinal Cord; Spinal Cord Injuries; Terpenes; Treatment Outcome | 2007 |
Alpha 2-adrenergic model of gastroparesis: validation with renzapride, a stimulator of motility.
Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cresols; Disease Models, Animal; Dogs; Duodenum; Eating; Gastric Emptying; Gastrointestinal Motility; Muscle, Smooth; Paralysis; Pyrroles; Receptors, Adrenergic, alpha; Serotonin Antagonists; Stomach Diseases; Technetium Tc 99m Sulfur Colloid | 1991 |
Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres.
Topics: Barium; Benzopyrans; Cromakalim; Humans; Hyperkalemia; In Vitro Techniques; Membrane Potentials; Muscles; Paralysis; Pyrroles; Tolbutamide | 1989 |